RESUMO
AIMS: Obtain varieties of Gluconacetobacter hansenii from original strain ATCC 23729 with greater efficiency to produce bacterial cellulose (BC) membrane with better dry mass yield for application as support of sustained antimicrobials' drug release. METHODS AND RESULTS: Application of different chemical and physical conditions (pH, temperature and UV light exposure) to obtain different G. hansenii varieties with high capacity to produce BC membranes. Characterization of the G. hansenii variants was performed by scanning electron microscopy (SEM) and optical microscopy of the colony-forming units. BC membrane produced was characterized by SEM, infrared spectroscopy and X-ray diffraction. The BC produced by variants isolated after incubation at 35°C showed elevated dry mass yield and high capacity of retention and sustained release of ceftriaxone antibiotic with the produced BC by original G. hansenii ATCC 23769 strain subjected to incubation at 28°C and with commercial BC. CONCLUSION: The application of different chemical and physical conditions constitutes an important method to obtain varieties of micro-organisms with dissimilar metabolism advantageous in relation to the original strain in the BC production. SIGNIFICANCE AND IMPACT OF THE STUDY: These results demonstrate the importance of in vivo studies for the application, in medicine, of BC membranes as support for antimicrobial-sustained release for the skin wound treatment.
Assuntos
Anti-Infecciosos/farmacocinética , Celulose , Preparações de Ação Retardada/química , Gluconacetobacter , Ceftriaxona/farmacocinética , Celulose/química , Celulose/metabolismo , Celulose/ultraestrutura , Gluconacetobacter/química , Gluconacetobacter/metabolismo , Microscopia Eletrônica de Varredura , Difração de Raios XRESUMO
A fim de avaliar a resposta biológica da hidroxiapatita sintética (HAP-91) nos alvéolos de felinos domésticos, este biomaterial foi implantado após extração do terceiro pré-molar inferior direito em 12 gatos e mantida por meio de uma membrana de celulose bacteriana. No lado esquerdo, os alvéolos foram apenas recobertos com a membrana de celulose bacteriana, formando o grupo-controle. Observou-se, durante a avaliação clínica, que todos os animais voltaram a comer normalmente ração úmida, sem apresentarem sinais de dor ou desconforto após a recuperação anestésica. A cicatrização da ferida cirúrgica ocorreu de forma satisfatória, sendo que a membrana de celulose bacteriana evitou a saída precoce da hidroxiapatita. Radiograficamente, aos 50 dias, todos os animais apresentaram radiopacidade óssea homogênea em ambos os lados. À análise histomorfométrica, observou-se adiantamento do processo de reparo do osso alveolar nos oito primeiros dias do grupo-tratado quando comparado ao grupo-controle, bem como atraso aos 30 dias, porém, aos 50 dias, ambos os grupos apresentavam porcentagem de tecido ósseo semelhante e morfologicamente normal. Os resultados sugerem que a hidroxiapatita é biocompatível, integra-se ao tecido ósseo alveolar e pode ser utilizada em felinos.
The biocompatibility of a material depends on its characteristics, as well as the species and the environment recipient. In order to evaluate the biological response of the synthetic hydroxyapatite (HAP-91) in feline dental alveoli, it was implanted in the right inferior third premolar after extraction in 12 cats and maintained through a bacterial cellulose membrane. On the left side the alveoli was covered with a bacterial cellulose membrane (control group). During clinical evaluations it was observed that the animals started to eat after the anesthetic recovery time, without clinical signs of pain. There was a satisfactory cicatrization of the surgical wound and the bacterial cellulose membrane aided in repairing the gum, avoiding the loss of the hydroxyapatite. Radiographs taken 50 days post surgery presented homogeneous bone radiopacity on both sides. The histological and histomorfometrical analysis showed a positive progress of the alveolar repair in the first 8 days in the treated group when compared to the control group and a delay at 30 days, however at 50 days both presented a similar and morphologically normal percentage of bone tissue. These findings suggest that HAP-91 is biocompatible and integrates into the feline alveolar bone.
Assuntos
Animais , Gatos , Durapatita/análise , Durapatita , Gatos/metabolismo , Gatos/microbiologia , Alvéolo Dental , Celulose/análiseRESUMO
The aim of this study was to develop and to evaluate the biological properties of bacterial cellulose-hydroxyapatite (BC-HA) nanocomposite membranes for bone regeneration. Nanocomposites were prepared from bacterial cellulose membranes sequentially incubated in solutions of CaCl(2) followed by Na(2)HPO(4). BC-HA membranes were evaluated in noncritical bone defects in rat tibiae at 1, 4, and 16 weeks. Thermogravimetric analyses showed that the amount of the mineral phase was 40%-50% of the total weight. Spectroscopy, electronic microscopy/energy dispersive X-ray analyses, and X-ray diffraction showed formation of HA crystals on BC nanofibres. Low crystallinity HA crystals presented Ca/P a molar ratio of 1.5 (calcium-deficient HA), similar to physiological bone. Fourier transformed infrared spectroscopy analysis showed bands assigned to phosphate and carbonate ions. In vivo tests showed no inflammatory reaction after 1 week. After 4 weeks, defects were observed to be completely filled in by new bone tissue. The BC-HA membranes were effective for bone regeneration.